By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluidigm today said that it has signed an agreement with AH Diagnostics to serve as its exclusive distributor in Sweden, Norway, Denmark, Iceland, and Finland.

Starting Feb. 1, Aarhus, Denmark-based AH will offer Fluidigm's portfolio of BioMark HD, EP1, and Access Array Systems and its arrays for a variety of genomic applications, including the new Deltagene and SNPtype arrays. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.